Professor Torsten Passie – The Science of Microdosing Psychdelics, A short review
In 2011, Jim Fadiman PhD described the intake of very low doses of psychedelics (e.g. 10–20 mcg of LSD). Claims about “microdosing” include better work performance, less procrastination, better mood, more creativity, psychological well-being and healthier life habits.
This lecture provides a rough overview on the history of microdosing and describes existing research on the effects of low doses of LSD, psilocybin and mescaline. Including; the place of microdosing and minidosing in the context of pharmacology, effects of psychedelics on the human psyche and organism, possible effects on performance, creativity, headaches, anxiety and depression, side effects and mechanisms of action, and concluding with thoughts on microdosing as a socio-psychological phenomenon assimilating psychedelics in our culture.
Torsten Passie MD, PhD is Professor of Psychiatry and Psychotherapy at Hannover Medical School (Germany) and currently Visiting Scientist at Goethe University in Frankfurt/Main (Germany).
He studied philosophy, sociology (MA) at Leibniz-University, Hannover and medicine at Hannover Medical School. He worked at the Psychiatric University Clinic in Zürich (Switzerland) and with Professor Hanscarl Leuner (Göttingen), the leading European authority on hallucinogenic drugs.
From 1998 to 2010 he was a scientist and psychiatrist at Hannover Medical school (Germany) where he researched the addictions and the psychophysiology of altered states of consciousness and their healing potential, including clinical research with hallucinogenic drugs (cannabis, ketamine, nitrous oxide, psilocybin). In 2012-2015 he was Visiting Professor at Harvard Medical School (Boston, USA).
Filmed at Breaking Convention 2019. Sponsored by the Beckley Foundation.
source
Leave feedback about this